This white paper explains how chart audits provide a high-fidelity view of real-world clinical practice in MedTech markets. It outlines how structured abstraction of anonymized patient charts delivers insights into treatment pathways, device utilization, clinical decision drivers, and unmet needs that are not captured in claims or survey data. The paper details best practices for study design, sampling, governance, and data quality to ensure compliance and analytical rigor. Strategic applications include opportunity sizing, launch planning, competitive positioning, and evidence generation. The paper concludes that chart audits are a critical complement to traditional market research, enabling evidence-based decision-making in complex device markets.

Join for free to read